Prostatitis syndromes and benign prostatic hyperplasia

Seminars in Roentgenology

Volumn 34, Issue 4, 1999, Pages 256-268

  Potter, S R ^a   Partin, A W ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DOXAZOSIN; FINASTERIDE; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAMSULOSIN; TERAZOSIN; ZINC;

ALGORITHM; ANTIBIOTIC THERAPY; CLINICAL EXAMINATION; DISEASE CLASSIFICATION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATITIS; REVIEW; SABAL; SCORING SYSTEM; TREATMENT PLANNING; URINALYSIS;

EID: 0032701988     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-198X(99)80004-2     Document Type: Article

References (103)

1. (abstr) Collins MM Stafford RS O'Leary P How common is prostatitis? A national survey of physician visits J Urol 157 1997 243
2. Moon TD Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis Urology 50 1997 543
3. (abstr) Roberts RO Jacobsen SJ Rhodes T A community-based study on the prevalence of prostatitis J Urol 157 1997 242
4. Drach GW Meares EM Fair WR Classification of benign disease associated with prostatic pain: Prostatitis or prostatodynia? J Urol 120 1978 266
5. December 7–8 Chronic Prostatitis Workshop Summary Statement 1995 National Institutes of Health Bethesda, MD
6. Meares EM Jr Acute and chronic prostatitis: Diagnosis and treatment Infect Dis Clin North Am 1 1987 855
7. Meares EM Jr Prostatitis and related disorders Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 1 1998 WB Saunders Philadelphia, PA 615 630
8. Bruce AW Willett WS Chadwick P The role of chlamydiae in genitourinary disease J Urol 126 1981 625
9. Brunner H Weidner W Schiefer H-G Studies of the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis J Infect Dis 147 1983 807
10. Poletti F Medicin MC Alinovi A Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis J Urol 134 1985 691
11. (suppl) Weidner W Schiefer HG Drauss H Chronic prostatitis: A thorough search for etiologically involved microorganisms in 1,461 patients Infection 19 1991 119
12. Berger RE Krieger JN Rothmen I Bacteria in the prostate tissue of men with idiopathic prostatic inflammation J Urol 157 1997 863
13. Shortliffe L Elliot JK Sellers RG Measurement of urinary antibodies to crude bacterial antigen in patients with chronic bacterial prostatitis J Urol 141 1989 632
14. Kirby RS Lowe D Bultitude MI Intra-prostatic urinary reflux: An aetiological factor in abacterial prostatitis Br J Urol 54 1982 729
15. Ramirez CT Ruiz JA Gomez AZ A crystallographic study of prostatic calculi J Urol 124 1980 840
16. Meares EM Jr Stamey TA Bacteriologic localization patterns in bacterial prostatitis and urethritis Invest Urol 5 1968 492
17. Nickel JC A practical approach to the management of prostatitis Techn Urol 1 1995 162
18. (abstr) Nigro M Nickel JC Valiquette L Diagnosis and treatment of prostatitis in Canada J Urol 157 1997 241
19. Nickel JC The pre and post massage test (PPMT): A simple screen for prostatitis Tech Urol 3 1997 38
20. Young D Portez D Treatment of Salmonella prostatitis with trimethoprim-sulfamethoxazole South Med J 71 1978 742
21. Ristuccia A Cunha B Current concepts in antimicrobial therapy of prostatitis Urology 20 1982 338
22. (suppl) Naber KG Use of quinolones in urinary tract infections and prostatitis Rev Infect Dis 11 1989 1321
23. Weinberger M Cytron S Servadio C Prostatic abscess in the antibiotic era Rev Infect Dis 10 1988 239
24. Dajani A O'Flynn J Prostatic abscess Br J Urol 40 1968 736
25. Sargent JC Irwin R Prostatic abscess: Clinical study of 42 cases Am J Surg 11 1931 334
26. Lee F Jr Lee F Solomon H Sonographic demonstration of prostatic abscess J Ultrasound Med 5 1986 101
27. Pfau A Prostatitis: A continuing enigma Urol Clin N Am 13 1986 695
28. Doble A Chronic prostatitis Br J Urol 74 1994 537
29. (suppl) Stamey TA Bushby SRM Bragonje J The concentration of trimethoprim in prostatic fluid: Nonionic diffusion or active transport? J Infect Dis 128 1973 686
30. Nickel JC Costerton JW Bacterial localization in antibiotic refractory chronic bacterial prostatitis Prostate 23 1993 107
31. Krieger J Egan K Comprehensive evaluation and treatment of 75 men referred to chronic prostatitis clinic Urology 38 1991 11
32. Meares EM Jr Prostatitis syndromes: New perspectives about old woes J Urol 123 1980 141
33. Echols RM Heyd A Tosiello RL Efficacy and safety of ciprofloxacin for chronic bacterial prostatitis Infect Med 12 1995 283
34. Weidner W Shielder HG Brahler C Refractory chronic bacterial prostatitis: A re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months J Urol 146 1992 350
35. Fair WR Wehner N The prostatic antibacterial factor: Identity and significance Marberger H Prostatic Disease vol 6 1976 Alan R. Liss New York 340 383
36. Partin AW Coffey DS The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 2 1998 WB Saunders Philadelphia, PA 1381 1428
37. Meares EM Jr Chronic bacterial prostatitis: Role of transurethral prostatectomy (TURP) in therapy Weidner W Brunner H Krause W Therapy of Prostatitis 1986 W. Zuckschwerdt Verlag Munich 193 197
38. Meares EM Jr Prostatodynia: Clinical findings and rationale for treatment Weidner W Brunner H Krause W Therapy of Prostatitis 1986 W. Zuckschwerdt Verlag Munich 207 212
39. Person B Gunnar R Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretions J Urol 155 1996 958
40. Nickel JC Effective office management of chronic prostatitis Urol Clin North Am 25 1998 677
41. Guess HA Arrighi HM Metter EJ The cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia Prostate 17 1990 241
42. Kortt MA Bootman JL The economics of benign prostatic hyperplasia treatment: A literature review Clin Ther 18 1996 1227
43. Abrams P New words for old: Lower urinary tract symptoms for “prostatism” BMJ 308 1994 929
44. nd International Consultation on BPH 1993 United Kingdom, Scientific Communication International Ltd. Channel Islands
45. McConnell J Barry M Bruskewitz R Benign prostatic hyperplasia: Diagnosis and Treatment Clinical Guidelines, Number 8 Rockville MD Agency for Health Care Policy and Research AHCPR Publications No. 94-0582 1994 Public Health Service, US Department of Health and Human Services
46. th International Consultation on BPH July 2–5, 1997, Paris, France 1998 Scientific Communications International Channel Islands 669 683
47. Roehrborn CG Chin HK Fulgham PF The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy J Urol 135 1986 1190
48. McConnell JD Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 2 1998 WB Saunders Philadelphia, PA 1429 1452
49. Mebust WK Holtgrewe HL Cockett ATK Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients J Urol 141 1989 242
50. Melchior J Valk WL Foret JD Transurethral prostatectomy in the azotemic patient J Urol 112 1974 643
51. Ornstein DK Garresh SR Smith DS The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate J Urol 157 1997 880
52. st International Consultation on Prostate Cancer June 20–22, 1996, Monaco 1996 Scientific Communications International Channel Islands 399
53. Barry MJ Fowler FJ Jr O'Leary MP The American Urological Association Symptom Index for benign prostatic hyperplasia J Urol 148 1992 1549
54. Abrams P Blaivas J Griffiths D The objective evaluation of bladder outlet obstruction (urodynamics) Cockett A Houry S Aso Y The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) 1993 Scientific Communications International Channel Islands, United Kingdom 115
55. Feneley MR Dunsmuir WD Pearce J Reproducibility of uroflow measurement: Experience during a double blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia Urology 47 1996 658
56. Reynard JM Peters TJ Linn C The value of multiple free flow studies in men with lower urinary tract symptoms Br J Urol 77 1996 813
57. McConnell JD Why pressure flow studies should be optional and not mandatory for evaluating men with benign prostatic hyperplasia Urology 44 1994 156
58. Holtgrewe LH The medical management of lower urinary tract symptoms and benign prostatic hyperplasia Urol Clin North Am 25 1998 555
59. (abstr) Roehrborn CG McConnell JD Is routine imaging of the urinary tract prior to prostatectomy a justifiable practice? J Urol 145 1991 266A
60. (suppl) Narayan P Tewari A Overview of alpha-blocker therapy for benign prostatic hyperplasia Urology 51 4A 1998 38
61. Roehrborn CG Siegel RL Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double blind, placebo-controlled studies Urology 48 1996 406
62. Lepor H Nieder A Feser J Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates Urology 49 1997 476
63. Lepor H Long term efficacy and safety of terazosin in patients with benign prostatic hyperplasia: Terazosin Research Group Urology 45 1995 406
64. Lepor H Dixon C Slawin K BPH—a glimpse into the future AUA News 2 1997 12
65. Beduschi MC Beduschi R Oesterling JE Alpha-blockade therapy for benign prostatic hyperplasia: From a nonselective to a more selective alpha-1A-adrenergic antagonist Urology 51 1998 861
66. Lowe FC Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: Pharmacodynamic effect Clin Ther 19 1997 730
67. Brooks TR Berman C Garnes D Prostatic effects induced in dogs by chronic or acute oral administration of 5-alpha-reductase inhibitors Prostate 9 1986 65
68. Andersen JT Ekman P Wolf H Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group Urology 46 1995 631
69. Nickel JC Fradet Y Boake RC Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: Results of a 2 year randomized controlled trial (The PROSPECT Study). Proscar Safety Plans Efficacy Canadian Two Year Study Can Med Assoc J 155 1996 1251
70. Tewari A Sinohara K Narayan P Transition zone volume and transition zone ratio: Predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients Urology 45 1995 258
71. Boyle P Gould AL Roehrborn CG Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials Urology 48 1996 398
72. McConnell JD Bruskewitz R Walsh P Finasteride decreases the incidence of BPH related surgery and acute urinary retention N Engl J Med 338 1998 557
73. Potter SR Partin AW Clinical utility, benefits, and limitations of percent free PSA Contemp Urol 11 1999 15 27
74. Wilt TJ Ishani A Stark G Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review JAMA 280 1998 1604
75. Oesterling JE Retropubic and suprapubic prostatectomy Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 2 1998 WB Saunders Philadelphia, PA 1529 1541
76. (suppl) Jepsen JV Bruskewitz RC Recent developments in the surgical management of benign prostatic hyperplasia Urology 51 1998 23
77. Stutzman RE Suprapubic Prostatectomy Marshall FM Textbook of Operative Urology, Operative Urology 1996 WB Saunders Philadelphia, PA 532 544
78. Wasson JH Reda DJ Bruskewitz RC Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia N Engl J Med 332 1995 75
79. Orandi A Transurethral incision of the prostate J Urol 110 1973 229
80. Orandi A Transurethral incision of the prostate compared with transurethral resection of the prostate in 132 matching cases J Urol 138 1987 810
81. Christensen MM Aagaard J Madsen P Transurethral resection versus transurethral incision of the prostate, a prospective randomized study Urol Clin North Am 17 1990 621
82. Katz PG Greenstein A Ratliff JE Transurethral incision of the bladder neck and prostate J Urol 144 1990 694
83. (suppl) Bruskewitz RC Christensen MM Critical evaluation of transurethral resection and incision of the prostate Prostate 3 1990 27
84. Dorflinger T Jensen FS Krarup T Transurethral prostatectomy compared with incision of the prostate in the treatment of prostatism caused by small benign prostate glands Scand J Urol Nephrol 26 1992 333
85. Mebust WK Transurethral surgery Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 2 1998 WB Saunders Philadelphia, PA 1511 1528
86. Kaplan SA Te AE Transurethral electrovaporization of the prostate: A novel method for treating men with benign prostatic hyperplasia Urology 45 1995 566
87. McCullough DL Minimally invasive treatment of benign prostatic hyperplasia Walsh PC Retik AB Vaughan ED ed 7 Campbell's Urology vol 2 1998 WB Saunders Philadelphia, PA 1479 1509
88. Harewood LM Cleeve LK O'Connell HE Transurethral needle ablation of the prostate (TUNA): Clinical results and ultrasound, endoscopic, and histologic findings in a pilot study of patients in urinary retention J Endourol 101 1995 33
89. Schulman CC Zlotta AR Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience Urology 45 1995 28
90. (suppl) Kaplan SA Minimally invasive alternative therapeutic options for lower urinary tract symptoms Urology 51 1998 32
91. Beduschi MC Oesterling JE Transurethral needle ablation of the prostate: A minimally invasive treatment for symptomatic benign prostatic hyperplasia Mayo Clin Proc 73 1998 696
92. Muschter R Hofstetter A Technique and results of interstitial laser coagulation World J Urol 13 1995 109
93. Kabalin JN Gilling PJ Fraundorfer MR Application of the holmium: YAG laser for prostatectomy J Clin Laser Med Surg 16 1998 21
94. Abbou C-C Payan C Viens-Bitker C Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: A double-blind randomized multicentre clinical trial Br J Urol 76 1995 619
95. Ramsey EW Miller PD Parsons K Novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: Results of a prospective multicentre clinical trial J Urol 158 1997 112
96. (abstr) Mayer R Blute M Bruskewitz R US multicenter study results of a new high temperature microwave system for BPH show improvement in patient symptoms and flow rates without compromise in morbidity and anesthetic needs J Urol 157 1997 95
97. Ahmed M Bell T Lawrence WT Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: A randomized, controlled, parallel study Br J Urol 79 1997 181
98. d'Ancona FCH Francisca EAE Witjes WPJ Thermotherapy versus transurethral resection for benign prostatic hyperplasia J Urol 158 1997 120
99. Ramsey EW Office treatment of benign prostatic hyperplasia Urol Clin North Am 25 1998 571
100. Kaplan SA Prostatic endoprosthetics Sosa ER Jenkins AD Albala DM Textbook of Endourology 1997 WB Saunders Philadelphia, PA 331 337
101. Harmon WJ Barrett DM Qian J Transurethral enzymatic ablation of the prostate canine model Urology 48 1996 229
102. Darson MF Barrett DM Transurethral enzyme injection—future management of benign prostatic hyperplasia Mayo Clin Proc 73 1998 908
103. Djavan B Larson TR Blute ML Transurethral microwave thermotherapy: What role should it play versus medical management in the treatment of benign prostatic hyperplasia Urology 52 1998 935